SynopsisA Nuclease (also archaically known as nucleodepolymerase or polynucleotidase) is an enzyme capable of cleaving the phosphodiester bonds between nucleotides of nucleic acids. The global well-known brands in Nuclease include New England Biolabs(14.61%), Me.....
SynopsisRosacea is a common skin condition characterized by redness and visible blood vessels on the face. The nose and cheeks are the most affected regions. The signs and symptoms of Rosacea are small, red, pus-filled bumps which may flare up periodically. About half.....
SynopsisThe global Antiparasitic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at.....
SynopsisGlobal Stress Supplements market is projected to reach US$ 2467.1 million in 2029, increasing from US$ 1645 million in 2022, with the CAGR of 5.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine .....
SynopsisThe global Morphine Sulfate Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while es.....
SynopsisRhinoplasty is a surgery to change the shape of the nose. It is performed to improve breathing conditions raised from birth defects or injury. It is also done for aesthetic reasons to change the shape of the nose. The global Rhinoplasty market was valued.....
SynopsisThe global Oral Probioics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Oral Probioics is estimated to increase from $ mill.....
SynopsisThe global Selective Glucocorticoid Receptor Modulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Selective Glucocortico.....
SynopsisMantle cell lymphoma (MCL) is a heterogeneous aggressive disease and remains incurable with current chemotherapies. The development of monoclonal antibody (mAb) has led to substantial achievement in immunotherapeutic strategies for B-cell lymphomas including M.....
SynopsisThe global OTC Cough, Cold & Allergy Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2.....
